Document:

Document

Exhibit 10.20
						
	
	MedAvail Technologies (US) Inc.
		Unit 1 - 6665 Millcreek Drive
		Mississauga, ON, L5N 5M4
		Tel: 1 (905) 812-0023

September 17, 2017
PRIVATE AND CONFIDENTIAL
Fraser Mackay
[***]
Dear Fraser,
Re: Offer of Employment
We at MedAvail Technologies Inc. ("MedAvail" or the "Company") believe that we are able to provide you with exciting and challenging career opportunities as part of our team.
MedAvail is pleased to extend to you an offer of employment on the terms and conditions outlined below.
1.Title.  You will be employed as Chief Operating Officer. You will be reporting directly to the Chief Executive Officer.
2.Commencement Date.  Your employment with us will begin on or about October 17, 2017 ("Commencement Date").
3.Duties and Position.  You agree to devote your whole working time to the performance of your duties and to perform your duties and responsibilities, as assigned to you from time to time by the Company, faithfully and to the best of your ability. These duties are subject to change to meet Company needs. You agree to act in the best interests of the Company at all times. While you are employed, you agree that you will not be employed by or obtain an ownership interest in any other entity or person who is a competitor of the Company, or where you may be placed in a position of conflict with the Company.
4.Non-Disparagement.  Further, without limiting the generality of the foregoing, while you remain employed and thereafter, you agree to refrain from making, directly or indirectly, any disparaging, defamatory, injurious or other negative or critical statements (including verbal statements, postings on Blogs, employer feedback sites, or other social media) about the Company, its subsidiaries, related entities and affiliates and each of their respective officers, directors, employees, servants, agents, and shareholders, whether to the Company's customers, employees, prospective customers or employees, directors, suppliers, members of the public, the media, or otherwise.
									
			
			INITIALS

2

5.Base Salary.  You will be paid an annual base salary of $250,000 CND (gross) subject to required statutory and other deductions which are hereby authorized by you. Your salary will be paid on a bi-weekly basis. With your authorization, this payment will be made directly into a bank account designated by you.
6.Vacation.  You will be entitled to five (5) weeks' vacation for every twelve months of employment (accruing at 2.08 days on a monthly basis). If you do not take your vacation in the applicable calendar year, you may use it in the first three (3) months of the following year, however, if you do not use it by that date, then any amount in excess of the statutory minimum amount will be forfeited. Vacation in the last twelve (12) months of employment will be pro-rated to reflect the actual time worked with the Company in that year.
7.Benefits.  You will be immediately eligible to participate in our group health benefit plans in accordance with their terms, the details of which will be available upon the commencement of your employment with the Company. The group benefit plans may be amended at the Company's sole discretion from time to time, and so long as the modified terms apply generally to employees, you agree that any such modification will not constitute constructive dismissal.
8.Short Term Incentive Plan. The Company's Short Term Incentive Plan ("STIP") is a discretionary incentive plan. You will be eligible for the opportunity to earn up to forty (40) percent of your base salary in the form of an STIP award, at the Company's sole discretion. The MedAvail Board of Directors will determine the corporate objectives and approve your departmental and individual objectives for each calendar year. Fifty (50) percent of any STIP award is based on the achievement of the Company's corporate objectives and the remaining fifty (50) percent is based on achievement of your departmental and individual objectives. The amount of any STIP award is determined at the sole discretion of the MedAvail Board of Directors and is not guaranteed to be provided in any given calendar year, or at all. The MedAvail Board of Directors will have sole discretion in determining whether any STIP award will be provided by way of cash or options granted pursuant to the Employee Stock Option Plan of MedAvail, Inc. For 2017, you will be eligible for the opportunity to earn a minimum of $75,000 in the form of a STIP award. In order for you to be eligible to receive any STIP award, you must be an active employee working at MedAvail on the date STIP awards are provided and you must not have given notice of resignation for a future date. For greater certainty, you are not entitled to any STIP awards that become payable following the termination of your employment for any reason, except those awards, if any, that become payable during the applicable minimum statutory notice period as required by the Employment Standards Act, 2000, as amended from time to time ("ESA").
9.Employee Stock Option Plan. Upon commencement of your employment, you will be granted fifty thousand (50,000) stock options in the equity capital of MedAvail, Inc., the US parent entity of the Company, at an exercise price equal to the fair market value of 
									
			
			INITIALS

3

common stock ofMedAvail, Inc. on the date of grant as determined by the Board (the "Options"). The Options will be issued pursuant to the Employee Stock Option Plan of MedAvail, Inc. (the "ESOP Plan"). Subject to the Option Agreement and detailed provisions of the ESOP Plan, your Options will vest over 4 years from the date of grant, at a rate of 1/48th per month. You will be required to sign an Option Agreement documenting your Option grant and in which you affirm that your rights with respect to the Options will be subject to the applicable terms in the Plan and your Option Agreement.
The Board of Directors may from time to time alter the terms and conditions of the ESOP Plan on a go forward basis, without notice to you.
10.Expenses.  You shall be entitled to be reimbursed for all reasonable expenses duly and properly incurred for the performance of your duties if approval of said expenses is obtained in advance.
11.Hours of Work.  In the execution of your duties, you will be expected to work not less than 40 hours per week, and in the evenings and on weekends where required. Your salary includes any hours worked in excess of forty-four (44) hours per week and your position is not eligible for overtime.
12.Policies.  You agree to abide by the rules, regulations, personnel practices, directives, programs and policies (the "Policies") of the Company as issued and in effect at any time during your employment. On an annual basis, or otherwise as may be reasonably required by the Company, you shall be required to certify your commitment to comply with the Policies, which are subject to amendment by the Company at any time and from time to time.
13.Conditions. This offer and your continued employment is conditional upon the following:
(i)You are legally authorized to work in Canada and you agree to indemnify the Company from any claims, damages, costs or expenses caused by the breach of this representation. At the request of the Company, you will provide proof that you are legally entitled to work in Canada;
(ii)You confirm that you have no obligations to third parties that would prevent you from performing your duties and responsibilities set out herein; and
(iii)You agree to submit to criminal, credit, reference and other background checks as may be arranged by the Company either directly or through its service provider(s), and the Company must be satisfied with the results thereof.
									
			
			INITIALS

4

14.Confidentiality
(a)You recognize that in the performance of your duties you will acquire detailed and confidential knowledge of the Company's operations and other confidential information and documents including, but not limited to, information and documents that are:
(i)of a technical nature, such as methods, know-how, processes, layouts, computer programs and similar items; and
(ii)of a business nature, such as information about operations or operational plans, personnel or personnel plans, development plans, marketing plans, sales or acquisition plans, and leasing plans; information about the Company's finances, costs or profits; information about the Company's business relationships and clients; and information about markets and the Company's current business plans and strategies,
together, referred to as "Confidential Information".
(b)You agree that you will safeguard the Confidential Information, and will not in any way, including through social media, use, divulge, furnish or make accessible to any person, other than in the fulfillment of your duties to the Company, or as required by law, either during your employment or at any time thereafter, any Confidential Information which is acquired by you in the course of your employment with the Company. These obligations will not be applicable to the extent that information is in the public domain at the time of its disclosure through no breach by you of this Agreement.
(c)You agree not to transfer (i) the contact information of Company customers with whom you have had direct business contact in the twelve (12) months immediately preceding the last day on which you provide services to the Company, or (ii) the contact information of Company employees with whom you work, to your Linkedln account or any other social media site. You specifically acknowledge that you have a positive obligation to protect, and not to disclose or use the Company's Confidential Information while engaging in social media activity of any nature.
(d)Any breach of these terms shall be grounds for immediate termination for cause. Additionally, you also agree and understand that any disclosure  or use made of Confidential Information, other than within the terms contemplated in this Agreement, may cause irreparable harm and damage to the Company as a result of which the Company may, at its option, pursue any and all remedies at law or in equity to which it may be entitled as a result of any such disclosure or use.
									
			
			INITIALS

5

(e)In performing your duties for the Company, you must not use or disclose any confidential or proprietary information belonging to another entity that you are not authorized to use or disclose.
15.Intellectual Property
(a)All Confidential Information, inventions, works, trade secrets, trade-marks, copyrights, moral rights, patents, designs, ideas, creations, developments, formulas, programs codes, drawings, sketches, compilations of information, analysis, experiments, data, formula, methods, processes, techniques, prototypes, products, samples,  equipment, tools, machines, and any modifications or improvements thereto and all benefit and advantage to be derived therefrom, relating in any way to the current or future business of the Company (collectively, the "Intellectual Property" or "IP"), created or conceived in whole or in part by you or on your behalf during all periods of time during which you are employed or engaged or contracted by the Company, or otherwise working on behalf of the Company, whether conceived during working hours and with the Company materials and supplies, or otherwise, shall be and remain the sole and exclusive property of the Company and you have no right, title or interest therein. You hereby irrevocably assign to the Company any and all right, title and interest that you may have now or in the future, or may have had, in and to the Intellectual Property, and waive any moral rights you may have therein.
(b)For greater certainty, the assignment includes any patent, copyright, industrial design, trade-mark and any other similar right pertaining to the Intellectual Property which you may have by virtue of having created, made, conceived or contributed to any such Intellectual Property, either solely or with others, in whole or in part, in the course of your employment or other working relationship with the Company and while concerned with or involved in the business carried on by the Company. You will promptly disclose all such Intellectual Property to the Company, and will not endeavour to benefit in any manner from such Intellectual Property. Any breach of this condition during your employment shall be grounds for immediate termination for cause.
(c)You will at any and all times, during the period of employment and after termination of your employment, do whatever is reasonably necessary or commercially reasonable to co-operate with the Company to apply for, secure, defend and enforce any Intellectual Property or deal with any issue relating to the business of the Company, at the expense of the Company. You acknowledge that you waive all moral rights in any Intellectual Property.
									
			
			INITIALS

6

16.Non-Solicitation
(a)It is a condition of this offer that you agree that while employed, and for a period of twelve (12) months after you leave the Company, regardless of the reason for your departure, that you will not:
(i)Solicit, directly or indirectly, or initiate contact with any Company Customer or Prospective Customer to offer such Company Customer or Prospective Customer a service or product competitive to that offered by the Company during your employment, and in the case of termination, on the Last Day, or to encourage a Company Customer to reduce or terminate its business relationship with the Company; or
(ii)Solicit, directly or indirectly, or encourage any employee or independent contractor working for the Company or in the six (6) months immediately preceding to the Last Day, to resign his/her employment or retainer with the Company.
(b)For purposes of this Agreement,
(i)"Company Customer" means any then current customer of the Company with whom you have had any direct business contact or in the case of termination, a customer of the Company with whom you had any direct business contact on the Last Day.
(ii)"Last Day" means in the twelve (12) months immediately preceding the day on which you cease to provide services to the Company.
(iii)"Prospective Customer" means any entity with respect to whom you assisted the Company in soliciting to purchase the Company products or services, and for which entity the Company has not ceased its efforts to obtain that entity's business or in the case of termination, was such an entity on the Last Day.
(iv)"Solicit, directly or indirectly" of a Company Customer or a Prospective Customer will expressly include, but not be limited to, (x) initiating communication or contact by you or your new employer, including through social media, or (y) advising those Company Customers or Prospective Customers that you are able to provide competitive services or products; provided, however, nothing herein is intended to limit communications or contacts that are unrelated to the Company's business, services or products.
(c)You agree and acknowledge that the restrictions provided in this section are tied to the Company Customers with whom you worked directly, and the Prospective Customers with whom you had direct business contact and are designed to protect 
									
			
			INITIALS

7

the relationship between the Company and those customers, so that a specified geographic limitation is not required.
17.Reasonableness.  You agree that the protections for the business described in sections 14 to 16, and section 19 are necessary to protect the business and its relationships with its customers, but are narrow enough not to impede your ability to earn a livelihood from other entities who are not Company Customers or Prospective Customers. You agree the restrictions are designed only to limit your access to Company Customers, Prospective Customers and persons working for the Company.  You also agree that any violation of these restrictions will result in irreparable harm to the Company, and consequently, in addition to pursuing any damages or other remedial action arising from the breach, the Company may proceed to obtain injunctive proceedings to restrain any breach or threatened breach of these restrictions. You expressly waive any right to contest whether a breach of these restrictions would result in irreparable harm.
18.Termination of Employment. You agree that your employment may be terminated as follows:
(a)By you, upon your resignation, by providing the Company with two (2) weeks' notice which notice the Company may waive in full or in part. If the Company does not require that you complete all or a portion of the resignation notice period, it may direct that you not attend at work, and such direction will not constitute a constructive termination. The Company will pay your base salary for that portion of the two (2) week resignation notice period that it directs you not to report to work.
(b)Following the Probationary Period, by the Company, without cause, by providing you with the greater of (x) that minimum amount of notice as is prescribed by the Employment Standards Act, 2000 ("ESA") (which will range from one (1) to eight (8) weeks' notice, depending on your length of service with the Company and its predecessor) or at the Company's sole discretion, payment of base salary in lieu thereof and, if applicable, payment of statutory severance pay, and (y) two (2) weeks' notice per completed year of service, or, at the Company's discretion, payment of base salary in lieu thereof, based on service with the Company from the Commencement Date to a maximum of fifty-two (52) weeks' notice or payment in lieu thereof. This latter amount referenced in 18(b) (y) is inclusive of statutory severance pay, if owed, it being understood that if working notice is given then statutory severance pay will also be paid, to the extent applicable. Additionally, the Company will continue to make its regular premium contributions to the benefit plans in which you are then participating and you will be eligible to participate in those benefit plans in accordance with the terms of the governing plans for the minimum statutory notice period.
The amounts provided for in this section are in full satisfaction of any entitlement owed upon termination under statute, contract or at common law. No further amount or entitlement is owed or will be provided upon termination without cause 
									
			
			INITIALS

8

except as outlined in this section. You agree upon payment that you have no claim, action or cause of action against the Company or any of its officers, directors or employees for any greater payment or other entitlement arising upon the termination of your employment. You agree that if your employment is constructively dismissed, your termination entitlement shall be as set out in Section 18(b) herein.
(c)By the Company, immediately, for cause. If your employment is terminated for cause, no amount as notice or payment in lieu of notice is required or will be provided.
19.Return of Property.  You acknowledge, understand and agree that all memoranda, notes, records, charts, formulae, data, software, source code, object code, Confidential Information and other documents made, received, held or used by you during the course of your employment shall be the property of the Company and shall be delivered by you to the Company upon request at any time during the course of employment or on termination of employment along with all other property belonging to the Company in your possession or under your control. You agree to return all Confidential Information stored on any electronic device such as a blackberry or iphone ("Information System") not owned or controlled by the Company and shall delete all such Confidential Information in such a manner that it cannot be undeleted. The Company may require you to produce such an Information System for inspection, and/or a certificate affirming the destruction and non-retention of the Confidential Information.
20.No Expectation of Privacy.  You acknowledge that you have no expectation of privacy with regard to use of email, internet, voicemail or Company provided computer systems as the Company may monitor usage at any time. Do not store any personal information on the Company's systems that you do not want the Company to view.
21.Independent Legal Advice.  You acknowledge that you have read and understood this Agreement and have been advised by us to seek independent legal advice and have been given a reasonable opportunity to seek and obtain such advice before signing the agreement.
22.Severability.  If any provision contained in this Agreement (or part thereof) is determined to be unenforceable in whole or in part by a Court of competent jurisdiction, such invalid provision (or part thereof) shall be severed and the remaining terms will remain in full force and effect.
23.Survival of Terms. The obligations set out in sections 14 through 19 and any other term necessary to give efficacy thereto shall survive the termination, resignation or expiration of your employment or other working relationship, as applicable.
24.Entire Agreement.  This Agreement constitutes the entire agreement between you and the Company. Any representations, oral or written, that are not expressly included in this Agreement are superseded and of no force or effect.
									
			
			INITIALS

9

25.Amendment. The terms described in this Agreement will remain in effect and apply, even if you are promoted, transferred or demoted, unless agreed otherwise in writing. Notwithstanding the foregoing, except for the termination section which can only be amended upon mutual agreement, the Company may unilaterally amend the terms of this Agreement upon providing to you that written notice of the change equivalent to the amount of notice required to be provided to you under section 18(b), above.
26.Counterparts. This Agreement may be executed simultaneously in counterparts (including by means of electronically transmitted reproductions of signature pages), each of which shall be deemed an original, but both of which together constitute one and the same instrument.
27.Governing Law. The law of Ontario governs the interpretation of this Agreement.
[Remainder of this page is intentionally left blank]
									
			
			INITIALS

10

We look forward to you joining MedAvail. If you choose to voluntarily accept this offer, please return an executed copy of this letter to us.
			
	Yours truly,
	
	MedAvail Technologies Inc.
	Per:
	
	/s/ Mary Cardoni
	Mary Cardoni - VP, Human Resources

ACCEPTANCE
I have had the opportunity to review this offer of employment, understand its terms, and accept the terms offered above. I confirm that there are no terms which have been promised to me other than those described above. I acknowledge that I am able to consult with legal counsel, at my own cost, and that I am voluntarily accepting this offer.
In addition to the confidentiality obligations described herein you agree that during your employment with MedAvail you shall not discuss, share or disclose any information regarding your salary and compensation to any other employee of MedAvail, its affiliates and or its subsidiaries. You agree that any such breach of this obligation will constitute cause for purposes of termination of employment.
									
			
	Fraser Mackay		Date:
			
			
	Witness		Date:

									
			
			INITIALSDocument

Exhibit 10.21
Execution Version

PRODUCT DISTRIBUTION AGREEMENT
THIS PRODUCT DISTRIBUTION AGREEMENT (the "Agreement") is made this 25th day of October, 2018, (the "Effective Date") by and between Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation having offices at 255 Technology Park, Lake Mary, Florida 32746 ("Distributor"), and MedAvail Pharmacy Inc., an Arizona corporation having offices at 1430 East Fort Lowell Road, Tucson, Arizona 85719 ("Company"). Distributor and Company are each referred to in this Agreement as a "Party," collectively, the "Parties."
WHEREAS, Company is a pharmacy that dispenses pharmaceutical products and offers associated patient services and;
WHEREAS, Distributor wholesales certain products to Its customers, which Include physicians, physician group practices, and certain health care institutions and facilities located in the United States and Puerto Rico; and
WHEREAS, the Parties desire to enter into this Agreement so that Distributor can distribute pharmaceutical or biological products to Company.
NOW THEREFORE, in consideration of the mutual agreements and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:
ARTICLE I
PRODUCTS AND SERVICES
1.1PRODUCT. This Agreement governs Distributor's distribution of those products set forth in Exhibit D, Products and Pricing ("Products"), which is attached hereto and incorporated by reference herein. Products may be removed and Product Pricing may be modified from time to time by Distributor upon notice to Company. Products may be added by mutual written agreement by the parties.
1.2LINE OF CREDIT. Immediately upon execution of the Agreement Company will cooperate In good faith to complete all documentation, including but not limited to credit applications and financial responsibility agreements, required for the establishment of an appropriate line of credit offered by Distributor to Company for the purchase of Products. The Parties will periodically review the line of credit. Distributor In its sole right may modify the credit line accordingly upon provision of written notice to Company. For the purpose of clarification, in the event of conflict between this Agreement and the credit application or financial responsibility agreements, this Agreement shall control.
1.3COMPANY FACILITIES. Company facilities eligible to purchase under this Agreement are listed in Exhibit A. The Parties may, from time to time, add or remove facilities upon mutual agreement. Company shall provide notification of such facility updates to Distributor at least five (5) days in advance of the desired effective date of change.
1.4DISTRIBUTION AND SHIPPING TERMS. Distributor will ship all Products in compliance with Distributor's current Shipping Policy, which may be modified from time to time without Company's consent, the current version is attached hereto as Exhibit C.
1

1.5PRODUCT RETURNS. All Product returns shall be made in accordance with Distributor standard returns policy in effect, which Is attached hereto as Exhibit B and Incorporated by reference herein. Returns policy may be modified from time to time without Company's consent.
1.6OWN USE. Company represents, warrants and covenants that all Products purchased through Distributor are: (i) intended for Company's "Own Use" as that term is defined by the United States Supreme Court in Abbott Labs v. Portland Retail Druggists Assoc., 425 U.S. 1 (1976) and (ii) not for resale to any individual or entity, Including without limitation any distributor, wholesaler, retail pharmacy, or other health care company or facility.
1.7RECALLS. If requested to do so in writing by Distributor, Company will cooperate fully with Distributor in recalling or returning any Product that Distributor believes should not be sold or used. Company will maintain complete and accurate records of all Products used by it in order to facilitate compliance with this section. To the extent allowed by law, regulation, and ethical requirements, Company will comply with Distributors reasonable written instructions concerning communications with the public regarding the procedures to be observed during a recall return of any Product.
1.8FORECAST. On a monthly basis, Company shall provide to Distributor an updated forecast of expected demand for all Products listed on Exhibit D. In the format specified in Exhibit E. Company agrees to make good faith effort to coordinate changes in demand with Distributor and to purchase Distributors remaining inventory on hand in the case of a reduction of demand for a Product.
1.9Quarterly Business Review. On at least a quarterly basis, the Parties agree to meet to discuss the business relationship and any additional services that may be available or required.
ARTICLE II
PRICES, REBATES AND PAYMENT
2.1PAYMENT TERMS. Distributor's invoices for Product ("Invoice(s)") shall be due and payable by Company within 45 days from the date on the Invoice. Invoices for Products shall reflect the payment terms and dating set forth under this Agreement, including the actual calendar date of payment expected for each invoice. All terms are based on cash repayment.
2.2PRICE. The price Company will pay Distributor for Products is set forth in Exhibit D.
2.3RIGHT OF FIRST REFUSAL. In the event Company receives a bona fide offer from an alternate authorized distribution source for a Product at a price, Including all rebates and other incentives, If any, lower than currently offered by Distributor (the "Lower Offer"), Company shall provide Distributor with reliable supporting evidence in writing, reasonably satisfactory to Distributor, of such offer. Distributor shall, within five (5 business days of Distributors' receipt of such written notice from Company, either adjust the price (which may include associated rebates and other incentives, if any) being charged to Company for the affected Product to match the Lower Offer or provide written notice to Company that the Product shall be withdrawn from the Agreement.
2.4PRICE PROTECTION. Distributor shall make commercially reasonable efforts to supply Products ordered as requested In each purchase order with quantities up to [***] of forecasted utilization provided by Company in accordance with Section 1.8.
In the event that Distributor is unable to supply Company with Products ordered due to supply constraints from supplier and a higher cost alternate Product is purchased by Company from Distributor due to such inability to supply, collection of the difference in price between the alternate 
2

Product and the Exhibit A Product may be available for collection from supplier ("Price Protection"). If such Price Protection is offered by supplier:
(a)The Parties agree to work in good faith and use commercially reasonable efforts to create any supporting information required for submission of a Price Protection claim, for such costs to supplier.
(b)Distributor agrees to remit appropriate costs collected as a result of a Price Protection claim to Company within 30 days of receipt.
(c)If no payment from supplier to Distributor results from a Price Protection claim, no payment shall be due to Company from Distributor.
ARTICLE III
TERM AND TERMINATION
3.1TERM. Unless and until this Agreement is terminated as provided for herein, this Agreement shall have a term of two (2) years, commencing on the Effective Date. Following the initial term, this Agreement shall be renewed automatically for additional one-year terms unless either Party shall have given the other written notice of non-renewal at least sixty (60) days prior to the expiration of the then current term.
3.2TERMINATION. This Agreement is made In good faith based on the assumption that early termination shall not be required. Notwithstanding the foregoing, early termination shall be permissible as follows:
(a)By either Party with sixty (60) days' written notice for any reason.
(b)Immediately by either Party if such Party provided written notice detailing a material breach of this Agreement and the breaching Party failed to cure the breach within thirty (30) days of the date of the notice.
(c)Immediately with written notice, by either Party, in the event that:
(i)the other Party shall file any petition under any bankruptcy, reorganization, Insolvency or moratorium laws, or any other law or laws for the relief of or in relation to the relief of debtors;
(ii)there shall be filed against the other Party any Involuntary petition under any bankruptcy statute or a receiver or trustee shall be appointed to take possession of all or a substantial part of the assets of the Party that has not been dismissed or terminated within sixty (60) days of the date of such filing or appointment;
(iii)the other Party shall make a general assignment for the benefit of creditors or shall become unable, or admit in writing Its inability, to meet its obligations as they mature;
(iv)the other Party shall institute any proceedings for liquidation or the winding up of its business other than for purposes of reorganization, consolidation, or merger;
(v)the other Party's financial condition shall become such as to endanger completion of its performance in accordance with the terms and conditions of this Agreement;
(vi)the other Party is unable to perform its duties for a period of thirty (30) days.
(d)Immediately upon notification by either Party if the terms of this Agreement are determined by either Party in good faith to be inconsistent with any applicable laws, statutes, regulations, and rules (and reasonable interpretations thereof and guidance related thereto) (collectively "Applicable Law"), or upon a change in law pursuant to Section 7.12.
3

ARTICLE IV
CONFIDENTIALITY AND DATA
4.1CONFIDENTIALITY. Each Party shall take all reasonable actions and do all things reasonably necessary to ensure that any Information contained in this Agreement, as well as any information that is disclosed by one Party ("Disclosing Party") to the other (Receiving Party") under this Agreement, which includes, without limitation (i) nonpublic Information relating to the Disclosing Party's technology, products, services, processes, data, customers, business plans and methods, promotional and marketing activities, finances and other business affairs, (ii) third-party Information that the Disclosing Party Is obligated to keep confidential and Indicates to the Receiving Party that the information is confidential (collectively, "Confidential Information"), shall not be disclosed or used for purposes outside this Agreement. The foregoing prohibition shall not apply to disclosures: (a) to the receiving Party's attorney or accountant; (b) made pursuant to a request from a legal or regulatory authority; (c) by the Receiving Party to its Affiliate, as defined below (provided such Affiliate is subject to the confidentiality restrictions at least as stringent as set forth herein), and for the purpose of this section "Affiliate" shall mean an entity in which the Receiving Party maintains an ownership position or an entity under common ownership or control with the Receiving Party; or (d) that are required pursuant to a court order or by law; provided that the Receiving Party gives the Disclosing Party reasonable advance written notice to allow the Disclosing, Party to seek a protective order or other appropriate remedy (except to the extent that the Receiving Party's compliance with the foregoing would cause it to violate an order of the governmental entity or other legal requirement) and uses commercially reasonable efforts to obtain confidential treatment for any Confidential Information so disclosed.
The foregoing prohibition shall not apply to information that: (i) a Party can show it knew prior to disclosure or was within Receiving Party's possession without obligation of confidentiality; (ii) is or becomes generally available to the public knowledge through no fault of said Party; (iii) is lawfully disclosed by a third party on a non-confidential basis, provided that, to the Receiving Party's knowledge, such source is not under an obligation of confidentiality or (iv) Is Independently developed by the Receiving Party under circumstances not involving a breach of this Agreement by the Receiving Party. This Section 4.1 shall survive any termination of this Agreement for a period of five (5) years thereafter. Each Party shall either return to the other Party, or destroy, all Confidential Information received hereunder upon the expiration or termination of this Agreement, except that each Party may retain one (1) copy of such Confidential Information in order to satisfy any future legal obligations it may have. Notwithstanding anything to the contrary contained herein, if reasonably necessary, Distributor shall be permitted to disclose to potential and existing customers of Distributor (and any potential purchaser of Distributor) the general terms of this Agreement. All Confidential Information will remain the exclusive property of the Disclosing Party. The Disclosing Party's disclosure of Confidential Information will not constitute an express or implied grant to the Receiving Party of any rights to or under the Disclosing Party's patents, copyrights, trade secrets, trademarks or other intellectual property rights. Except to the extent permitted by Applicable Law in the absence of any express license or other grants of rights, neither party will use any trade name, trademark, logo or any other proprietary rights of the other Party (or any of its Affiliates) in any manner without prior written authorization of such use by an appropriate corporate officer of such other Party
ARTICLE V
REPRESENTATIONS AND WARRANTIES
5.1STATUTORY AND REGULATORY COMPLIANCE.  Distributor  and Company shall comply with all Applicable Laws governing their activities related to this Agreement, including without limitation, 
4

laws related to fraud and abuse, false claims, privacy, provision of samples, and prohibition on kickbacks. Without limiting the generality of the foregoing, the Parties further agree as follows:
(a)Discounts/Rebates. Although Distributor does not submit claims or requests for payment to Medicare or Medicaid, the Parties have structured any discounts and rebates under this Agreement in a manner consistent with the applicable characteristics of the statutory discount exception (42 U.S.C. § 1320a-7b(b)(3)(A)) and the discount safe harbor (42 C.F.R. § 1001.952(h)). The terms pursuant to which any discount or rebate will be paid are fixed and are set forth in this Agreement and the attached Exhibits. This Agreement is not dependent on, and does not operate in conjunction with, either explicitly or implicitly, any other arrangement or agreement between Company and Distributor or either Party's Affiliates. Neither Company nor Distributor are, by virtue of this Agreement or otherwise, willfully offering, paying, soliciting, or receiving remuneration in return for referring an Individual to or from each other for the furnishing of any item or service reimbursed under the Medicare or a state healthcare programs or engaging in any other illegal inducement specified in the Anti­-Kickback Statute. Company represents and warrants that: (i) It will refrain from doing anything that would impede Distributor from meeting any reporting obligations Distributor may have under Applicable Law; (ii) no discount/rebate paid pursuant to this Agreement is intended in any way as a discount related to a drug formulary or drug formulary activities and no discount/rebate has been negotiated or discussed between the Parties in connection with any such drug formulary or formulary activities; (iii) Company is aware of and will comply with its obligations to accurately report any discounts or other information that must be disclosed under Applicable Law, for each Product for which a discount or rebate has been paid under this Agreement .To the extent required under Applicable Law, Distributor will report the discounts/rebates to appropriate Federal health care programs, and will, upon the request of a governmental agency, including the Secretary of Health and Human Services or a state healthcare agency, disclose information regarding the discounts/rebates to the requesting agency.
(b)Regulatory Approvals. Company represents and warrants that they are in compliance with Applicable Law in US and Canada and authorized to do business in the US. Upon request by Distributor, Company will provide necessary documentation and information related to licensure status as related to dispense of Product.
(c)Company represents and warrants that they are bound by the terms of this Agreement.
5.2FEDERAL PROGRAMS. Company represents, warrants, and certifies that neither it nor any of Its principals were or are debarred, suspended, proposed for debarment, otherwise determined to be Ineligible to participate In Federal health care programs (as that term is defined in 42 U.S.C. 1320a- 7b(f)), convicted of a criminal offense related to the provision of health care items or services, or currently the subject of any Office of Inspector General investigation (collectively, an "Adverse Enforcement Action"). Company shall notify Distributor immediately If Company or any of its principals becomes the subject of an Adverse Enforcement Action.
ARTICLE VI
INDEMNIFICATION, LIMITATION OF LIABILITY, AND INSURANCE
6.1MUTUAL INDEMNIFICATION.
(a)Distributor Indemnification. Distributor will defend, Indemnify and hold Company and its affiliates, officers, directors, agents and employees harmless from and against any loss, cost, damage, expense, or other liability, Including, without limitation, reasonable costs and attorney fees (collectively, "Damages") Incurred in connection with any and all actual or threatened third 
5

party claims, suits, Investigations, enforcement actions, or any other judicial or quasi-judicial proceeding ("Claims") arising out of (i) Distributor's negligent acts or omissions or willful misconduct, or (ii) Distributor's breach of any material term of this Agreement, Distributor shall have no obligation to indemnify Company in connection with any Claims caused by or based upon the negligence or intentional misconduct of Company or Company's breach of this Agreement.
(b)Company Indemnification. Company will defend, indemnify and hold Distributor and its affiliates, officers, directors, agents and employees harmless from and against any Damages incurred in connection with any and all Claims arising out of (i) Company's negligent acts or omissions or willful misconduct, or (ii) Company's breach of any material term of this Agreement. Company shall have no obligation to Indemnify Distributor in connection with any Claims caused by or based upon the negligence or intentional misconduct of Distributor or Distributor's breach of this Agreement.
(c)Notification. As a condition of indemnification, the Party seeking Indemnification shall notify, to the extent possible under Applicable Law, the indemnifying Party in writing promptly upon learning of any Claim for which indemnification may be sought hereunder. The Indemnifying Party shall have a right to participate in the defense of such Claim, and the Parties will cooperate in good faith in such defense. No Party shall have an obligation to Indemnify the other Party as described herein with respect to any Claim settled without the mutual written consent of both Parties, which consent shall not be unreasonably withheld.
6.2LIMITATION OF LIABILITY.
(a)With the exception of each Party's confidentiality and indemnification obligations herein, in no event shall either Party be liable to the other under this Agreement for any special, incidental, indirect, exemplary, or consequential damages, whether based on breach of contract, warranty, tort (including negligence), lost profits or savings, punitive damages, injury to reputation, loss of customers or business, product liability, or otherwise, regardless of whether such Party has been advised of the possibility of such damage. The Parties acknowledge and agree that the foregoing limitations of liability are a condition and material consideration for their entry into this Agreement.
(b)Company's liability for direct damages incurred with respect to this Agreement is limited to no more than ten million dollars ($10,000,000) per Claim. Notwithstanding the foregoing, Company's liability for third party claims shall not be limited.
6.3INSURANCE. Distributor and Company shall maintain such policies of general liability, professional liability, and other Insurance of the types and in amounts customarily carried by their respective businesses. Notwithstanding the foregoing, Company shall, at a minimum, maintain throughout the term of this Agreement commercial products liability coverage, either through commercial insurance or a self-insured retention pool, in an amount no less than ten million dollars ($10,000,000). Each Party shall provide the other with reasonable proof of insurance upon written request.
ARTICLE VII
GENERAL TERMS
7.1RESERVATION OF RIGHTS. Each Party reserves all right, title, and interest in and to its patents, copyrights, trade secrets, know-how, and other intellectual property used, disclosed, or made available under or in connection with this Agreement. All rights and licenses to intellectual property 
6

not granted by a Party to the other Party under this Agreement are reserved by the first Party and Its suppliers.
7.2INTELLECTUAL PROPERTY. Each Party reserves all right, title, and interest in and to Its company, product, and service names, logos, brands, trademarks, service marks, trade dress, and other proprietary designations (collectively, "Marks"). Upon the other Party's reasonable, written request, each Party agrees to provide the other Party with samples of any materials using the other Party's Marks. All use of a Party's Mark's is and shall remain subject to such Party's reasonable quality control and brand usage guidelines. All goodwill arising from use of a Party's Marks shall inure exclusively to such Party's benefit.
7.3NOTICE. Any notice, demand, request, consent, or approval required or permitted hereunder shall be in writing, in the English language, and shall be delivered: (a) personally; (b) by certified mail, return receipt requested, postage prepaid; (c) by facsimile transmission; or (d) by overnight courier by a nationally recognized courier service, to the address indicated below or to such other address as may be designated In writing by each Party from time to time. A copy of any notice will also be sent via email to the address Indicated below.
									
	If to Company:
		
			
		MedAvail Pharmacy Inc.
	
		6665 Millcreek Dr. Unit 1
	
		Mississauga, ON Canada L5N 5M4
	
		Attn: 	Legal Department

			
	If to Distributor:
		
			
		Express Scripts, Inc.
	
		c/o Priority Healthcare Distribution, Inc.
	
		One Express Way
	
		St. Louis, MO 63121	
		Attn:	Legal Department

			
	With a copy to:
		
			
		Priority Healthcare Distribution, Inc.
	
		255 Technology Park Drive
	
		Lake Mary, FL 32746
	
		Attn:	General Manager

All such communications shall be deemed to have been received by the intended recipient: (i) on the day actually received If delivered personally; (ii) five (5) business days following deposit in the United States Mail if sent by certified mail; (iii) upon confirmation of receipt of a facsimile transmission If sent by facsimile; or (iv) on the next business day if sent by overnight courier.
7.4SEVERABILITY. In the event any portion of this Agreement not material to the remaining portions hereof shall be held illegal, void, or Ineffective, the remaining portions hereof shall remain in full force and effect. Subject to the consent of both Parties, such consent not to be unreasonably withheld, if any of the terms or provisions of this Agreement are in conflict with any Applicable Laws, then such terms or provisions shall be deemed Inoperative to the extent that they may conflict with such Applicable Laws and shall be deemed to be modified to conform to such Applicable Laws.
7

7.5AUDIT. No more than once during any twelve (12) month period during the term of this Agreement, either Party shall permit a certified public accountant, engaged by the auditing Party and reasonably acceptable to the other Party ("Auditor") to audit the other's records relating to the twelve (12) month period preceding the date when the audit is conducted. Such audit shall be limited to tracking of rebates, data reports, and chargeback reports. If either Party elects to conduct an audit, the other Party agrees to make available upon thirty (30) days' advance written notice, during normal business hours, such documents and personnel in a manner as not to unduly interfere with the audited Party's operations. If any audit reveals (a) an error in the calculation, reporting, or payment of any rebates; or (b) that an overcharge or undercharge incurred, in the case of an error by either Party, such Party shall provide a written response or explanation, correct any error, and remit any monies due within fifteen (15) days after receiving notice of the error or overcharge. Any Auditor hired by either Party must both enter into a confidentiality agreement executed by both Parties. The Party performing the audit shall be responsible for any expenses associated with the audit. Audits during December and January are limited to regulatory need.
7.6ENTIRE AGREEMENT. With regard to the issues addressed herein, this Agreement and the Exhibits attached hereto contain the entire agreement and understanding of the Parties, and supersede any and all prior agreements and understandings regarding the same subject matter.
7.7AMENDMENT. No amendment, modification, revision, representation, warranty, promise or waiver of or to this Agreement shall be effective unless the same shall be In writing and signed by both Parties. Notwithstanding the foregoing removal of any Products, or adjustments to the Product Price reflected in Exhibit D (Products and Pricing) may be reflected upon written notification from Distributor to Company, Exhibit B (Returned Goods Policy) and Exhibit C (Shipping Policy) may be modified with a written notification from Distributor to Company. Upon the effective date of the change, the Exhibit(s) will be deemed amended to reflect such change.
7.8COUNTERPARTS. This Agreement may be executed in any number of counterparts, all of which together shall constitute one and the same instrument.
7.9ASSIGNMENT. Neither Party may assign this Agreement without the written consent of the other; provided, however, that Distributor may assign this Agreement to any entity that, directly or indirectly, wholly owns or controls Distributor or any affiliate that is, directly or Indirectly, wholly owned or controlled by any entity that, directly or Indirectly, wholly owns or controls Distributor.
7.10DELEGATION OF RESPONSIBILITIES. Distributor may engage a third party to conduct certain administrative functions on its behalf and may subcontract portions of certain limited functions and responsibilities of this Agreement, including, but not limited to, data compilation and reporting services, financial accounting and processing services, or any other function relating to any of Distributor's obligations set forth herein. Company agrees to cooperate with Distributor's reasonable requests relating to Distributor's engagement of any such third party. Such third party must perform in a manner conforming to this Agreement and will be bound by confidentiality restrictions no less restrictive than are set forth in Section 4.1 of this Agreement. Distributor shall retain full responsibility and liability for the performance of any subcontracted service.
7.11FORCE MAJEURE. Notwithstanding anything to the contrary herein, neither Party shall be liable in any manner for any delay to perform its obligations under this Agreement where the cause of such delay Is beyond a Party's reasonable control, including, without limitation, any delay or failure due to strikes, labor disputes, riots, earthquakes, storms, hurricanes, floods or other extreme weather conditions, fires, explosions, acts of God, embargoes, war or other outbreak of hostilities, government acts or regulations, or the failure or inability of carriers, suppliers, delivery services, or telecommunications providers to provide services necessary to enable a Party to perform its obligations hereunder. In such event, the Parties agree to use their commercially reasonable efforts 
8

to resume performance as soon as reasonably possible under the circumstances giving rise to the Party's failure to perform, provided, however, if performance is not restored within thirty (30) calendar days, either Party may terminate this Agreement pursuant to Section 3.2(c)(vi).
7.12CHANGE IN LAW. If, subsequent to the Effective Date (a) there is a change to any existing Applicable Laws; (b) any Applicable Law is promulgated, enacted, enforced, or otherwise applied; or (c) any decree, order, judgment, or permanent Injunction is entered or enforced by any court of competent jurisdiction or any other government agency relating to the terms of this Agreement, which in the good faith opinion of Company or Distributor adversely and materially affects or will adversely and materially affect its business by reason of the terms of this Agreement, the affected Party shall notify the other Party in writing and the Parties will promptly negotiate alternative terms that would not adversely and materially affect the affected Party's business, and that would, subject to Applicable Law, provide reasonably equivalent benefits to both Parties as the modified or deleted terms. If the Parties do not so reach a mutually satisfactory agreement within thirty (30) days after notice from the affected Party, the relevant adverse terms may be terminated or, if the relevant adverse terms are material to the overall Agreement, the Agreement may be terminated pursuant to Section 3.2(d).
7.13WAIVER. No waiver of any term of this Agreement shall be valid unless waived in writing and signed by the Party against whom the waiver is sought. The failure of either Party to require performance by the other Party of any provision of this Agreement shall not affect, in any way, the right to require such performance at any time thereafter.
7.14INDEPENDENT CONTRACTORS. Nothing in this Agreement is intended to create any relationship between Distributor and Company other than as independent contractors and neither Party, nor any of their employees, staff, agents, officers, or directors shall be construed to be the agent, fiduciary, employee, or representative of the other.
7.15NON-EXCLUSIVITY. Company acknowledges that Distributor has agreements with multiple entities, including other specialty pharmacies, provider groups and group purchasing organizations. Distributor acknowledges that Company has agreements with multiple entities, including other wholesalers, pharmaceutical manufacturers and group purchasing organizations.
7.16CHOICE OF LAW. This Agreement and performance of the obligations hereunder, shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflicts of laws provision therein.
7.17SURVIVAL. The confidentiality and indemnification obligations described In this Agreement shall survive the termination of this Agreement. These ongoing obligations shall be binding upon both Parties regardless of the reason for the termination of this Agreement.
7.18THIRD PARTY BENEFICIARIES. This Agreement is not a third party beneficiary contract, and, therefore, there are no third party beneficiaries to this Agreement.
[Remainder of page left intentionally blank. Signatures follow on next page.]
9

IN WITNESS WHEREOF, the undersigned, duly authorized, has executed this Agreement, effective as of the Effective Date.
																		
	PRIORITY HEALTHCARE DISTRIBUTION, INC.
			MedAvail Pharmacy Inc.		
						
	By:	/s/ Earl English		By:	/s/ Ed Kilroy	
						
	Print
Name:	Earl English		Print
Name:	Ed Kilroy	
						
	Title:	President		Title:	CEO	
						
	Date:	10.31.18		Date:	10/26/18	
						

						
		

10

EXHIBIT A
COMPANY FACILITIES

																														
	Facility DEA	Facility NPI	Facility
Name	Facility
Name 2	Facility
Address	Facility
Address
2	Facility
City	Facility
State	Facility
Zip	Facility
Class of
Trade
	FA6977512	1477076255	SpotRx
Pharmacy	Tucson	1430 E. Ft.
Lowell	#120	Tucson	AZ	85719	Retail

	TBD*
Application
in process	1346720349	SpotRx
Pharmacy	Phoenix	2196 E.
Camelback
Rd.	#200	Phoenix	AZ	85016	Retail

*Pending Licensure, this facility will be deemed an eligible facility under this Agreement upon approval of licensure.
11

EXHIBIT B
RETURNED GOODS POLICY

Return Policy
CuraScript SD Specialty Distribution (CuraScript SD) requires a Return Goods Authorization (RGA) form for products to be returned. An RGA form can be obtained by calling the Customer Service Department at 877.599.7748 or by using www.curascriptonline.com. All products must be returned to CuraScript SD within 30 days of RGA request; products received without a signed RGA will not be accepted and will be destroyed. RGA documentation must match lot numbers of returned products*.
Products Eligible for Return
Only products purchased from CuraScript SD will be eligible for return All products returned must be in the original package (unopened, unmarked, and in original containers) and stored and shipped in compliance with PDMA guidelines to be eligible for credit. CuraScript SD reserves the right to determine the eligibility of product to be returned for credit upon receipt and inspection a return processing fee of up to 20% will apply.
Shipping Errors or Damages
The CuraScript SD Customer Service Department must be notified on the same day of delivery for refrigerated products and within 72 hours of the day of delivery for non-refrigerated products.
Expired Products
Expired products are subject to the manufacturers return policy; customer will only receive credit equal to credit granted by the manufacturer, less a 20% return processing fee.
CuraScript SD will arrange for pickup of all authorized products to be returned. CuraScript SD will charge a freight fee for this service, unless the return is the result of a CuraScript SD error.
Items Not Eligible for Return
1.Discontinued products or products deemed non-returnable by the manufacturer
2.Opened, marked or repackaged products
3.Controlled or hazardous drugs
4.Special ordered products
5.Drop shipped products
6.Any products not purchased from CuraScript SD
7.Partial boxes/cases (unless as a result of a recall)
*CuraScript SD follows all federal and state regulations regarding returns and pedigree requirements.
Conditions for Eligibility
1.Only products purchased from CuraScript SD are eligible for return.
2.All products must be received by CuraScript SD within 30 days of the RGA to be eligible for credit.
3.Product returned must be accompanied by signed RGA documentation and match quantity, lot and expiration of products received.
4.Product returned must be received in the original package undamaged, unopened and unmarked to be eligible for credit.
5.Pharmaceutical products must be stored and shipped in compliance with PDMA guidelines to be eligible for credit. Unless otherwise authorized by CuraScript SD, refrigerated products must maintain cold chain conditions.
6.Only products purchased from CuraScript SD are eligible for return.
12

7.All products must be received by CuraScript SD within 30 days of the RGA to be eligible for credit.
8.Product returned must be accompanied by signed RGA documentation and match quantity, lot and expiration of products received.
9.Product returned must be received in the original package undamaged, unopened and unmarked to be eligible for credit.
10.Pharmaceutical products must be stored and shipped in compliance with PDMA guidelines to be eligible for credit.
11.Unless otherwise authorized by CuraScript SD, refrigerated products must maintain cold chain conditions.
13

Exhibit C
SHIPPING POLICY

All orders over $200 are shipped prepaid by CuraScript SD. Products may arrive in separate shipments based on product requirements; stock availability may also affect the number of shipments per order.
•Standard Shipping Services
CuraScript SD provides Next Day service on all refrigerated products. Second Day delivery is customary on all other pharmaceuticals, while medical supplies, fluids and hazardous materials are shipped via Ground service. Friday-for-Monday delivery on refrigerated products is offered at no additional charge.
•Emergency Shipping Options
CuraScript SD offers expedited and emergency shipping options within the United States, Puerto Rico and Guam for an additional charge. Please contact your Account Manager to request emergency shipping.
14

Exhibit D
PRODUCTS AND PRICING

												
	NDC	Manufacturer	Description	Product
Price

15

Exhibit E 
Product Forecast1

												
	NDC	Product Description	Next Monthly
Forecast
(Purchase Units)
	Average Monthly
Demand, Prior Three
Months
(Purchase Units)

1 TO BE PROVIDED BY COMPANY ON EXECUTION OF THE AGREEMENT AND UPDATED ON A MONTHLY BASIS.
16

FIRST AMENDMENT TO
PRODUCT DISTRIBUTION AGREEMENT
The First Amendment to Product Distribution Agreement (the “First Amendment”) is effective upon the date of last signature (the “Effective Date”) and is entered into by and between Priority Healthcare Distribution Inc. d/b/a CuraScript SD Specialty Distribution, a Florida corporation with a principal place of business at 255 Technology Park, Lake Mary, Florida 32746 (“CuraScript”) and MedAvail Pharmacy Inc., an Arizona corporation with a principal place of business at 1430 East Fort Lowell Road, Tucson, Arizona 85719 (“Company”). Distributor and Company may be referred to in this Amendment individually as a “Party,” or collectively, the “Parties.”
WITNESSETH:
WHEREAS, Company and CuraScript entered into a Product Distribution Agreement with an effective date of October 25th, 2018; and
WHEREAS, Company and CuraScript desire to amend the terms of the Agreement as set forth herein.
NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein, the Parties intending to be legally bound, agree to amend the Agreement as follows:
1.Exhibit A, “Company Facilities,” is deleted in its entirety and replaced with the Exhibit A attached hereto.
2.Except as modified herein, all other terms of the Agreement remain in full force and effect. To the extent the provisions of this First Amendment conflict with provisions of the Agreement, the provisions of this First Amendment shall control. Defined terms that are used but not defined herein have the meanings assigned to them in the Agreement.
IN WITNESS WHEREOF, the Parties have hereunto signed this Amendment effective as of the date set forth above.
															
	Company			CuraScript	
	MedAvail Pharmacy Inc.			Priority Healthcare Distribution, Inc. d/b/a
CuraScript SD Specialty Distribution	
					DocuSigned by:
	By:	/s/ Neil Prezioso		By:	/s/ Earl English
					
	Name:	Neil Prezioso		Name:	Earl English
					
	Title:	Chief Pharmacy Officer		Title:	President, CuraScript SD
					
	Date:	4/1/2020		Date:	04/02/2020 | 8:06 AM CDT
					

Page 1 of 2
FOIA NOTICE: This document contains proprietary and confidential information including internal policies, trade secrets, and commercial and financial information, any and all of which are protected from disclosure under the Freedom of Information Act (FOIA), pursuant to 5 U.S.C. § 552(b)(4) and 45 C.F.R. Part 5.

Exhibit A
COMPANY FACILITIES
																								
	Facility
DEA	Facility
NPI	Facility
Name	Facility Address
	Facility
City	Facility
State	Facility
Zip
	Facility
Class of
Trade
	FA6977512	1477076255	SpotRX
Pharmacy	1430 E. Ft.
Lowell, #120	Tucson	AZ	85719	Retail
	FM785153	1346720349	SpotRX
Pharmacy	2196 E.
Camelback Rd.,
#200	Phoenix	AZ	85016	Retail
	FS9030254	1629618087	SpotRX
Pharmacy	6800
Orangethorpe
Avenue, Ste. D	Buena
Park	CA	90620	Retail
	TBD*	TBD	SpotRX
Pharmacy	1431 Truman St.,
Unit M	San
Fernando	CA	91340	Retail
	TBD*	TBD	SpotRX
Pharmacy	23521 Ridge
Route Dr., Suite B	Laguna
Hills	CA	92653	Retail
	TBD*	TBD	SpotRX
Pharmacy	2501 Cherry Ave.,
Suite 145	Signal
Hill	CA	90755	Retail

* This facility will not be an eligible facility under this Agreement until it is licensed and has a Facility DEA number. Company shall provide notice to Distributor of any such approvals prior to a facility being considered eligible.
Page 2 of 2
FOIA NOTICE: This document contains proprietary and confidential information including internal policies, trade secrets, and commercial and financial information, any and all of which are protected from disclosure under the Freedom of Information Act (FOIA), pursuant to 5 U.S.C. § 552(b)(4) and 45 C.F.R. Part 5.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]